Cargando…
JISTIC: Identification of Significant Targets in Cancer
BACKGROUND: Cancer is caused through a multistep process, in which a succession of genetic changes, each conferring a competitive advantage for growth and proliferation, leads to the progressive conversion of normal human cells into malignant cancer cells. Interrogation of cancer genomes holds the p...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873534/ https://www.ncbi.nlm.nih.gov/pubmed/20398270 http://dx.doi.org/10.1186/1471-2105-11-189 |
_version_ | 1782181363564150784 |
---|---|
author | Sanchez-Garcia, Felix Akavia, Uri David Mozes, Eyal Pe'er, Dana |
author_facet | Sanchez-Garcia, Felix Akavia, Uri David Mozes, Eyal Pe'er, Dana |
author_sort | Sanchez-Garcia, Felix |
collection | PubMed |
description | BACKGROUND: Cancer is caused through a multistep process, in which a succession of genetic changes, each conferring a competitive advantage for growth and proliferation, leads to the progressive conversion of normal human cells into malignant cancer cells. Interrogation of cancer genomes holds the promise of understanding this process, thus revolutionizing cancer research and treatment. As datasets measuring copy number aberrations in tumors accumulate, a major challenge has become to distinguish between those mutations that drive the cancer versus those passenger mutations that have no effect. RESULTS: We present JISTIC, a tool for analyzing datasets of genome-wide copy number variation to identify driver aberrations in cancer. JISTIC is an improvement over the widely used GISTIC algorithm. We compared the performance of JISTIC versus GISTIC on a dataset of glioblastoma copy number variation, JISTIC finds 173 significant regions, whereas GISTIC only finds 103 significant regions. Importantly, the additional regions detected by JISTIC are enriched for oncogenes and genes involved in cell-cycle and proliferation. CONCLUSIONS: JISTIC is an easy-to-install platform independent implementation of GISTIC that outperforms the original algorithm detecting more relevant candidate genes and regions. The software and documentation are freely available and can be found at: http://www.c2b2.columbia.edu/danapeerlab/html/software.html |
format | Text |
id | pubmed-2873534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28735342010-05-20 JISTIC: Identification of Significant Targets in Cancer Sanchez-Garcia, Felix Akavia, Uri David Mozes, Eyal Pe'er, Dana BMC Bioinformatics Software BACKGROUND: Cancer is caused through a multistep process, in which a succession of genetic changes, each conferring a competitive advantage for growth and proliferation, leads to the progressive conversion of normal human cells into malignant cancer cells. Interrogation of cancer genomes holds the promise of understanding this process, thus revolutionizing cancer research and treatment. As datasets measuring copy number aberrations in tumors accumulate, a major challenge has become to distinguish between those mutations that drive the cancer versus those passenger mutations that have no effect. RESULTS: We present JISTIC, a tool for analyzing datasets of genome-wide copy number variation to identify driver aberrations in cancer. JISTIC is an improvement over the widely used GISTIC algorithm. We compared the performance of JISTIC versus GISTIC on a dataset of glioblastoma copy number variation, JISTIC finds 173 significant regions, whereas GISTIC only finds 103 significant regions. Importantly, the additional regions detected by JISTIC are enriched for oncogenes and genes involved in cell-cycle and proliferation. CONCLUSIONS: JISTIC is an easy-to-install platform independent implementation of GISTIC that outperforms the original algorithm detecting more relevant candidate genes and regions. The software and documentation are freely available and can be found at: http://www.c2b2.columbia.edu/danapeerlab/html/software.html BioMed Central 2010-04-14 /pmc/articles/PMC2873534/ /pubmed/20398270 http://dx.doi.org/10.1186/1471-2105-11-189 Text en Copyright ©2010 Sanchez-Garcia et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Software Sanchez-Garcia, Felix Akavia, Uri David Mozes, Eyal Pe'er, Dana JISTIC: Identification of Significant Targets in Cancer |
title | JISTIC: Identification of Significant Targets in Cancer |
title_full | JISTIC: Identification of Significant Targets in Cancer |
title_fullStr | JISTIC: Identification of Significant Targets in Cancer |
title_full_unstemmed | JISTIC: Identification of Significant Targets in Cancer |
title_short | JISTIC: Identification of Significant Targets in Cancer |
title_sort | jistic: identification of significant targets in cancer |
topic | Software |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873534/ https://www.ncbi.nlm.nih.gov/pubmed/20398270 http://dx.doi.org/10.1186/1471-2105-11-189 |
work_keys_str_mv | AT sanchezgarciafelix jisticidentificationofsignificanttargetsincancer AT akaviauridavid jisticidentificationofsignificanttargetsincancer AT mozeseyal jisticidentificationofsignificanttargetsincancer AT peerdana jisticidentificationofsignificanttargetsincancer |